Portugal · Health startup
Portugal · RUBYnanomed
RUBYnanomed is a Portuguese biotechnology company founded in 2018 as a spin-off from the International Iberian Nanotechnology Laboratory (INL).
Funding reportedLast round: Seed
About RUBYnanomed
RUBYnanomed is a Portuguese biotechnology company founded in 2018 as a spin-off from the International Iberian Nanotechnology Laboratory (INL).
Based in Braga, Portugal, the company specializes in non-invasive cancer progression monitoring using liquid biopsy technology. With a team of around 10 employees, RUBYnanomed operates in the Monitoring Equipment and Life Sciences sectors. The company's flagship product, the RUBYchip®, is a microfluidic device that isolates circulating tumor cells (CTCs) from unprocessed whole blood. This device captures CTCs based on their size and deformability, providing oncologists with real-time insights into cancer progression and therapeutic resistance. RUBYnanomed also engages in pre-clinical trials across multiple European hospitals and collaborates with pharmaceutical companies to develop Companion Diagnostics. The company has received funding from various investors and was recognized in the EIC Accelerator program for its innovative contributions to healthcare and biotechnology.
What company datasets say RUBYnanomed raised
Funding, as reported
The company, in detail
What they build
Known for
health careliquid biopsycompanion diagnosticsinvitro diagnosiscancer monitoringhospital & health carehealthmedical devicescirculating tumour cellswellness & fitness servicesoncologyhealthcaremicrofluidic devicesb2bwellness & fitness
Built with from their website
Microsoft 365Outlook
- Sector
- Health
- Industry code
- NAICS 541714, 334516
- Region
- Braga
- Full record
- Every detail in the company directory
Health in Portugal
Startups like it
Is this your company?
Add your raise, your deck and your story, and put RUBYnanomed in front of investors. Or tell us what we have wrong.